Gastroenterology
News
Zoster vaccination does not appear to increase flare risk in patients with immune-mediated inflammatory disease
For the study, investigators used medical claims from IBM MarketScan in patients aged 50-64 years, and data from the Centers for Medicare and...
News
IBD study hints at cause of postacute COVID
Persistent viral antigens could be behind multiorgan symptoms: The majority of patients with gut antigen persistence had symptoms of postacute...
News
What explains poor adherence to eosinophilic esophagitis therapy?
Among patients with eosinophilic esophagitis, less than half complied with long-term medical or dietary therapy, according to a new study.
Conference Coverage
Finding HBV ‘cure’ may mean going ‘back to the drawing board’
Development of new HBV drugs looks more complicated than initially expected, and it’s time to refine and refocus goals, according to one...
Conference Coverage
Statins in NAFLD: Taking a closer look at benefits
Statins could have multiple benefits in NAFLD, but there has been little insight into how they may be exerting such effects.
News
Irritable bowel syndrome therapy removed from market (again)
Zelnorm, a short-term IBS-C treatment, has been removed from the market. The drug manufacturer cited “business concerns.”
News
Persistent abdominal pain: Not always IBS
The challenge of diagnosing and treating persistent abdominal pain can be tackled by greater awareness of the multiple potential causes of this...
News
More reflux after sleeve gastrectomy vs. gastric bypass at 10 years
Importantly, the cumulative incidence of Barrett’s esophagus was similar after both procedures and markedly lower than reported in previous trials...
News
Acute hepatitis cases in children show declining trend; adenovirus, COVID-19 remain key leads
Adenovirus remains the most commonly detected virus in acute hepatitis in children, found in 53% of cases overall.
Conference Coverage
Fatty liver disease drives rise in liver cancer deaths
“The burden of this disease [NAFLD] is going up, and it will be the most important disease of the next decade or so.”